Prudence is never excessive: Caution warranted in 5-aminosalicylic acid derivatives withdrawal for ulcerative colitis. [PDF]
Gravina AG, Pellegrino R, Federico A.
europepmc +1 more source
Practices and perceptions of 5-aminosalicylic acid use in Crohn's disease: a nationwide survey of physicians in Korea by KASID Guidelines Taskforce Team. [PDF]
Bae JH +18 more
europepmc +1 more source
Optimizing 5-Aminosalicylic Acid Maintenance Treatment in Ulcerative Colitis from the Patient and Physician Perspective: A Cross-sectional Multicenter Study. [PDF]
Amano T +30 more
europepmc +1 more source
Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey. [PDF]
Limsrivilai J +13 more
europepmc +1 more source
Pectinase responsive nanoplatform for oral targeted delivery 5-aminosalicylic acid and zinc coordination driven nanozyme in inflammatory bowel disease treatment. [PDF]
Lin Y +11 more
europepmc +1 more source
Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis.
Mikami Y +5 more
europepmc +1 more source
Persistence of newly prescribed 5-aminosalicylic acid in patients with ulcerative colitis: A nationwide comprehensive database study. [PDF]
Noda T +6 more
europepmc +1 more source
Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy. [PDF]
Sanapalli BKR +3 more
europepmc +1 more source
Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance. [PDF]
Matsumoto H +9 more
europepmc +1 more source
Risk factors for non-responsiveness to 5-aminosalicylic acid in patients with ulcerative colitis identified using retrospective clinical study and Mendelian randomization. [PDF]
Ye ZN +7 more
europepmc +1 more source

